Polaris Group (TPE:6550)

Taiwan flag Taiwan · Delayed Price · Currency is TWD
37.35
-0.55 (-1.45%)
Jul 10, 2025, 2:38 PM CST
-47.32%
Market Cap 28.78B
Revenue (ttm) 87.67M
Net Income (ttm) -2.75B
Shares Out 770.43M
EPS (ttm) -3.65
PE Ratio n/a
Forward PE n/a
Dividend n/a
Ex-Dividend Date n/a
Volume 303,644
Average Volume 568,041
Open 37.30
Previous Close 37.90
Day's Range 37.30 - 38.30
52-Week Range 26.35 - 71.80
Beta 0.21
RSI 41.87
Earnings Date Aug 25, 2025

About Polaris Group

Polaris Group, together with its subsidiaries, offers biotechnology, drug testing, and contract development and manufacturing services. The company engages in the research, development, manufacture and sale of new drugs. It develops ADI-PEG 20 for the treatment of various cancer indications. It also provides healthcare consulting, staffing, and MDS solutions. The company was founded in 1988 and is based in Tampa, Florida. [Read more]

Industry Biotechnology
Sector Healthcare
Founded 1988
Employees 165
Stock Exchange Taiwan Stock Exchange
Ticker Symbol 6550
Full Company Profile

Financial Performance

In 2024, Polaris Group's revenue was 107.00 million, an increase of 1330.29% compared to the previous year's 7.48 million. Losses were -2.50 billion, 67.7% more than in 2023.

Financial Statements

News

There is no news available yet.